HER-2/NEU – FISH Test
AED2,820.00
The HER-2/NEU – FISH Test is a highly precise diagnostic tool used to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, it provides accurate, reliable, and early detection of HER-2 status, which is crucial for determining targeted therapy eligibility, such as Herceptin (trastuzumab) treatment. This test offers higher sensitivity and specificity compared to immunohistochemistry (IHC), reducing false-positive or false-negative results. Its rapid turnaround time and clinically validated methodology make it a gold standard for personalized cancer treatment, ensuring optimal therapeutic decisions and improved patient outcomes.
Description
HER-2/NEU – FISH Test: Precision Diagnostics for Targeted Cancer Treatment
The HER-2/NEU – FISH Test is a highly specialized diagnostic tool designed to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, this test provides highly accurate, reliable, and quantitative results, enabling oncologists to make informed treatment decisions.
### Key Features:
✔ Gold Standard in HER-2 Testing – FISH is considered the most precise method for detecting HER-2 gene amplification, ensuring superior accuracy over immunohistochemistry (IHC) alone.
✔ Early and Definitive Diagnosis – Identifies HER-2 gene amplification at the molecular level, allowing for early intervention and personalized treatment planning.
✔ Guides Targeted Therapy – Essential for determining eligibility for HER-2-targeted therapies such as **Trastuzumab (Herceptin), Pertuzumab (Perjeta), and T-DM1 (Kadcyla)**, improving patient outcomes.
✔ Rapid Turnaround Time – Provides results within a clinically relevant timeframe, ensuring timely treatment decisions.
✔ High Sensitivity & Specificity – Reduces the risk of false positives or negatives, offering confidence in treatment selection.
### Benefits to the Patient & Physician:
🔹 Personalized Treatment Approach – Helps tailor therapy to the patient’s specific cancer profile, maximizing treatment efficacy.
🔹 Improved Prognosis & Survival Rates – HER-2-positive patients benefit significantly from targeted therapies, leading to better disease management and survival outcomes.
🔹 Minimizes Unnecessary Treatments – Prevents the administration of ineffective therapies, reducing side effects and healthcare costs.
🔹 Essential for Breast & Gastric Cancer Management – Recommended for patients diagnosed with invasive breast cancer or gastric cancer to determine HER-2 status.
### Who Should Get This Test?
✔ Patients diagnosed with breast cancer or gastric cancer where HER-2 status is unknown or needs confirmation.
✔ Individuals with equivocal (borderline) IHC results (IHC 2+), requiring definitive HER-2 gene amplification assessment.
✔ Patients being considered for HER-2-targeted therapies, ensuring optimal treatment selection.
### Why Choose the HER-2/NEU – FISH Test?
With its unparalleled accuracy and ability to guide life-saving treatments, the **HER-2/NEU – FISH Test** is an indispensable tool in modern oncology. By identifying HER-2 gene amplification with precision, this test empowers physicians to make data-driven decisions, ensuring that patients receive the most effective, targeted therapies available.
Take control of cancer treatment with precision diagnostics—choose the HER-2/NEU – FISH Test for accurate, reliable, and life-changing results.
Reviews
There are no reviews yet.